Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD₂ Coated Nanoparticles

• Amanda Tivnan ,

  Contributed equally to this work with: Amanda Tivnan, Wayne Shannon Orr

  Affiliations Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland, National Children’s Research Centre, Our Lady’s Children’s Hospital, Dublin, Ireland

  ⨯
• Wayne Shannon Orr ,

  Contributed equally to this work with: Amanda Tivnan, Wayne Shannon Orr

  Affiliations Department of Surgery, St. Jude Children’s Research Hospital, Memphis, Tennessee, United States of America, Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America

  ⨯
• Vladimir Gubala,

  Affiliation Biomedical Diagnostics Institute, Dublin City University, Dublin, Ireland

  ⨯
• Robert Nooney,

  Affiliation Biomedical Diagnostics Institute, Dublin City University, Dublin, Ireland

  ⨯
• David E. Williams,

  Affiliation Biomedical Diagnostics Institute, Dublin City University, Dublin, Ireland

  ⨯
• Colette McDonagh,

  Affiliation Biomedical Diagnostics Institute, Dublin City University, Dublin, Ireland

  ⨯
• Suzanne Prenter,

  Affiliations Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland, National Children’s Research Centre, Our Lady’s Children’s Hospital, Dublin, Ireland

  ⨯
• Harry Harvey,

  Affiliations Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland, National Children’s Research Centre, Our Lady’s Children’s Hospital, Dublin, Ireland

  ⨯
• Raquel Domingo-Fernández,

  Affiliations Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland, National Children’s Research Centre, Our Lady’s Children’s Hospital, Dublin, Ireland

  ⨯
• Isabella M. Bray,

  Affiliations Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland, National Children’s Research Centre, Our Lady’s Children’s Hospital, Dublin, Ireland

  ⨯
• Olga Piskareva,

  Affiliations Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland, National Children’s Research Centre, Our Lady’s Children’s Hospital, Dublin, Ireland

  ⨯
• Catherine Y. Ng,

  Affiliation Department of Surgery, St. Jude Children’s Research Hospital, Memphis, Tennessee, United States of America

  ⨯
• Holger N. Lode,

  Affiliation Department of Paediatrics and Paediatric Haematology/Oncology, University of Greifswald, Greifswald, Germany

  ⨯
• Andrew M. Davidoff,

  Affiliations Department of Surgery, St. Jude Children’s Research Hospital, Memphis, Tennessee, United States of America, Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America

  ⨯
• Raymond L. Stallings

  * E-mail: rstallings@rcsi.ie

  Affiliations Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland, National Children’s Research Centre, Our Lady’s Children’s Hospital, Dublin, Ireland

  ⨯